For additional information regarding sites, contact 844-687-8522 — Oklahoma City, Oklahoma

For additional information regarding sites, contact 844-687-8522 is a clinical research site located in Oklahoma City, Oklahoma, United States 73106.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

For additional information regarding sites, contact 844-687-8522 has participated in 2 clinical trials.

Therapeutic areas: Attention-deficit Hyperactivity Disorder, Schizophrenia.

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Oklahoma City

Browse all research sites in Oklahoma · View every site in Oklahoma City

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for For additional information regarding sites, contact 844-687-8522?

For additional information regarding sites, contact 844-687-8522 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has For additional information regarding sites, contact 844-687-8522 conducted?

For additional information regarding sites, contact 844-687-8522 has 2 clinical trials on record. Their work covers Attention-deficit Hyperactivity Disorder, Schizophrenia.

Is For additional information regarding sites, contact 844-687-8522 accredited by Crixeo Clinical Trials?

For additional information regarding sites, contact 844-687-8522 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about For additional information regarding sites, contact 844-687-8522?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.